arrow
E

Eva Hadaschik

universität essen
H指数:25
被引数:2,017

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Klinisches und immunpathologisches Spektrum des Immunglobulin-M-Pemphigoids: eine multizentrische Fallserie

IgM型天疱疮的临床和免疫病理谱:一项多中心病例系列

2025-12-110
OAAI
Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation loss

cKIT突变黏膜黑色素瘤中伊马替尼的显著治疗获益及其随后发生的KIT突变丢失

2025-10-250
OAAI
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series

免疫球蛋白M类天疱疮的临床和免疫病理学谱:一项多中心病例系列研究

2025-08-060
OA
Early versus late response to PD-1-based immunotherapy in metastatic melanoma

转移性黑色素瘤对PD-1-based免疫治疗的早期与晚期反应

2024-10-010
OAAI
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1-(Triple) wild type melanomas

BRAF-、RAS-和NF1-(三重) 野生型黑色素瘤中免疫检查点抑制剂的无进展生存期和总生存期缩短

2024-09-011
OA
Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma

BAP1-mutated非葡萄膜和葡萄膜黑色素瘤的临床和遗传学特征

2024-06-051
OAAI
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM

不同组织类型中肿瘤PD-L1表达与转移性黑色素瘤PD-1-based免疫治疗结果的相关性-DeCOG前瞻性多中心队列研究adorig/TRIM的分析

2023-10-0118
OAAI
Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis
2023-07-014
OAAI
Characterisation and outcome of RAC1 mutated melanoma
2023-04-017
PRE